- Home
- APLS vs CSQ Comparison
APLS vs CSQ Comparison
Compare APLS & CSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APLS | CSQ |
|---|---|---|
| Founded | 2009 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.0B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | APLS | CSQ |
|---|---|---|
| Price | $23.49 | $19.16 |
| Analyst Decision | Buy | |
| Analyst Count | 20 | 0 |
| Target Price | ★ $32.16 | N/A |
| AVG Volume (30 Days) | ★ 3.9M | 220.3K |
| Earning Date | 02-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.53% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $1,016,397,000.00 | N/A |
| Revenue This Year | $31.31 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $65.59 | ★ N/A |
| Revenue Growth | ★ 42.11 | N/A |
| 52 Week Low | $16.10 | $12.50 |
| 52 Week High | $30.53 | $16.45 |
Technical Indicators
Market Signals| Indicator | APLS | CSQ |
|---|---|---|
| Relative Strength Index (RSI) | 50.62 | 39.55 |
| Support Level | $22.29 | $18.73 |
| Resistance Level | $24.10 | $19.42 |
| Average True Range (ATR) | 1.18 | 0.23 |
| MACD | 0.15 | -0.07 |
| Stochastic Oscillator | 76.65 | 23.93 |
Price Performance
Historical ComparisonAbout APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About CSQ Calamos Strategic Total Return
Calamos Strategic Total Return Fund is a diversified, closed-end management investment company. The fund's objective is to provide total return through a combination of capital appreciation and current income. Its investment portfolio comprises equities, convertible securities, and high-yield corporate bonds.